{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:33:43Z","timestamp":1793324023873,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Diagnoses of perinatal opioid use disorder (OUD) continue to rise in the United States. Patients and providers report obstacles to OUD treatment access. Difficulties include legal ambiguity related to Social Services notification requirements following a birth to people using opioids or in medication-assisted treatment for OUD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Through semi-structured interviews, participant-observation, and a focus group conducted in a mostly rural, region of the Southern United States (where perinatal OUD is more prevalent), patients\u2019 and providers\u2019 perspectives about perinatal substance use treatment were initially sought for a larger study. The findings presented here are from a subset analysis of patients\u2019 experiences and perspectives. Following ethics review and exemption determination, a total of 27 patient participants were opportunistically, convenience, and\/or purposively sampled and recruited to participate in interviews and\/or a focus group. Data were analyzed using modified Grounded Theory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>When asked about overall experiences with and barriers to accessing perinatal substance use treatment, 11 of 27 participants reported concerns about Social Services involvement resulting from disclosure of their substance use during pregnancy. In the subset analysis, prevalent themes were<jats:italic>Fears of Social Services Involvement<\/jats:italic>,<jats:italic>Preparation for Delivery<\/jats:italic>, and<jats:italic>Providers Addressing Fears<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Perinatal OUD patients may seek substance use treatment with existing fears of Social Services involvement. Patients appreciate providers\u2019 efforts to prepare them for this potential reality. Providers should become aware of how their own hospital systems, counties, states, and countries interpret laws governing notification requirements. By becoming aware of patients\u2019 fears, providers can be ready to discuss the implications of Social Services involvement, promote patient-centered decision-making, and increase trust.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12884-021-03596-w","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T08:00:13Z","timestamp":1613635213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["\u201cThe elephant in the room;\u201d a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia"],"prefix":"10.1186","volume":"21","author":[{"given":"Catherine","family":"Leiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Cody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-3747","authenticated-orcid":false,"given":"Bayla M. M.","family":"Ostrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"issue":"1","key":"3596_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jrh.12328","volume":"35","author":"CHA Andrilla","year":"2019","unstructured":"Andrilla CHA, Moore TE, Patterson DG. Overcoming barriers to prescribing buprenorphine for the treatment of opioid use disorder: recommendations from rural physicians. J Rural Health. 2019;35(1):113\u201321 Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/jrh.12328. Cited 2019 Feb 1.","journal-title":"J Rural Health"},{"key":"3596_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","volume":"185","author":"K Kaltenbach","year":"2018","unstructured":"Kaltenbach K, O\u2019Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, et al. Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes. Drug Alcohol Depend. 2018;185:40\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3596_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s40501-017-0116-y","volume":"4","author":"K Saia","year":"2017","unstructured":"Saia K, Jones H, Terplan M. Pregnancy and the opioid epidemic. Curr Treat Options Psychiatry. 2017;4(2):184\u201395.","journal-title":"Curr Treat Options Psychiatry"},{"key":"3596_CR4","doi-asserted-by":"crossref","unstructured":"Haight SC. Opioid use disorder documented at delivery hospitalization \u2014 United States, 1999\u20132014. MMWR Morb Mortal Wkly Rep. 2018;67 Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/67\/wr\/mm6731a1.htm. Cited 2018 Nov 28.","DOI":"10.15585\/mmwr.mm6731a1"},{"key":"3596_CR5","volume-title":"Opioid use and opioid use disorder in pregnancy: clinical guidance","author":"ACOG","year":"2018","unstructured":"ACOG. Opioid use and opioid use disorder in pregnancy: clinical guidance. 2018. Available from: https:\/\/www.acog.org\/Clinical-Guidance-and-Publications\/Committee-Opinions\/Committee-on-Obstetric-Practice\/Opioid-Use-and-Opioid-Use-Disorder-in-Pregnancy. Cited 2018 Nov 28."},{"key":"3596_CR6","first-page":"745","volume":"82","author":"MB Alexander","year":"2014","unstructured":"Alexander MB. Denying the dyad: how criminalizing pregnant use harms the baby, taxpayers and vulnerable women. Tenn L Rev. 2014;82:745.","journal-title":"Tenn L Rev"},{"issue":"3","key":"3596_CR7","first-page":"164","volume":"79","author":"M Ramage","year":"2018","unstructured":"Ramage M, Ostrach B, Fagan B, Coulson CC. Stabilizing the mother-infant dyad for better outcomes from OB to FM caring for patients with perinatal opioid use disorder through the 4th trimester. N C Med J. 2018;79(3):164\u20135 Available from: http:\/\/www.ncmedicaljournal.com\/content\/79\/3\/164. Cited 2018 May 7.","journal-title":"N C Med J"},{"key":"3596_CR8","first-page":"6","volume-title":"Medications to treat opioid use disorder during pregnancy: information for providers","author":"SAMHSA","year":"2019","unstructured":"SAMHSA. Medications to treat opioid use disorder during pregnancy: information for providers; 2019. p. 6."},{"issue":"2","key":"3596_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/nad.12044","volume":"19","author":"L-M Buer","year":"2016","unstructured":"Buer L-M, Leukefeld CG, Havens JR. \u201cI\u2019m stuck\u201d: women\u2019s navigations of social networks and prescription drug misuse in central Appalachia. North Am Dialogue. 2016;19(2):70\u201384.","journal-title":"North Am Dialogue"},{"issue":"4","key":"3596_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/ADM.0000000000000491","volume":"13","author":"B Ostrach","year":"2019","unstructured":"Ostrach B, Leiner C. \u2018I Didn\u2019t want to be on Suboxone at first\u2026\u2019\u2013ambivalence in perinatal substance use treatment. J Addict Med. 2019;13(4):264\u201371.","journal-title":"J Addict Med"},{"issue":"5","key":"3596_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1377\/hlthaff.2019.00785","volume":"39","author":"DN Atkins","year":"2020","unstructured":"Atkins DN, Durrance CP. State policies that treat prenatal substance use as child abuse or neglect fail to achieve their intended goals: study examines the effect of state policies that treat prenatal substance use as child abuse or neglect on the incidence of neonatal abstinence syndrome and other factors. Health Aff. 2020;39(5):756\u201363.","journal-title":"Health Aff"},{"key":"3596_CR12","doi-asserted-by":"publisher","DOI":"10.1215\/9780822375180","volume-title":"addicted.pregnant.poor","author":"K Knight","year":"2015","unstructured":"Knight K. addicted.pregnant.poor. Raleigh: Duke University Press; 2015."},{"key":"3596_CR13","unstructured":"Wakeman SE, Jordan A, Beletsky L. When reimagining systems of safety, take a closer look at the child welfare system. Health affairs: Health Affairs Blog; 2020. Available from: https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20201002.72121\/full\/#.X33PusssAuw.twitter. Cited 2020 Oct 12"},{"key":"3596_CR14","unstructured":"Bowers O, Stewart J, Scott C, Thompson T-A, Zuniga C, Paltrow L, et al. SisterReach Report: Tennessee\u2019s Fetal Assault Law, understanding its impact on marginalized women. n.d.. Available from: https:\/\/www.sisterreach.org\/uploads\/1\/2\/9\/0\/129019671\/full_report.pdf. Cited 2020 Apr 24."},{"issue":"6","key":"3596_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","volume":"26","author":"C Angelotta","year":"2016","unstructured":"Angelotta C, Weiss CJ, Angelotta JW, Friedman RA. A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women. Women\u2019s Health Issues. 2016;26(6):595\u2013601 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1049386716301694. Cited 2019 Dec 30.","journal-title":"Women\u2019s Health Issues"},{"issue":"6","key":"3596_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.wombi.2020.01.006","volume":"33","author":"D O\u2019Rourke-Suchoff","year":"2020","unstructured":"O\u2019Rourke-Suchoff D, Sobel L, Holland E, Perkins R, Saia K, Bell S. The labor and birth experience of women with opioid use disorder: a qualitative study. Women and Birth. 2020;33(6):592\u20137.","journal-title":"Women and Birth."},{"issue":"11","key":"3596_CR17","doi-asserted-by":"publisher","first-page":"e1914135","DOI":"10.1001\/jamanetworkopen.2019.14135","volume":"2","author":"D Goodman","year":"2019","unstructured":"Goodman D, Whalen B, Hodder LC. It\u2019s time to support, rather than punish, pregnant women with substance use disorder. JAMA Netw Open. 2019;2(11):e1914135.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3596_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40352-015-0015-5","volume":"3","author":"R Stone","year":"2015","unstructured":"Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health Justice. 2015;3(1):2. https:\/\/doi.org\/10.1186\/s40352-015-0015-5 Cited 2019 Nov 15.","journal-title":"Health Justice"},{"issue":"1","key":"3596_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/GRF.0b013e3182802da0","volume":"56","author":"PE Hill","year":"2013","unstructured":"Hill PE. Perinatal addiction: providing compassionate and competent care. Clin Obstet Gynecol. 2013;56(1):178\u201385.","journal-title":"Clin Obstet Gynecol"},{"key":"3596_CR20","doi-asserted-by":"publisher","unstructured":"Kramlich D, Kronk R, Marcellus L, Colbert A, Jakub K. Rural postpartum women with substance use disorders. Qual Health Res. 2018. https:\/\/doi.org\/10.1177\/1049732318765720.","DOI":"10.1177\/1049732318765720"},{"key":"3596_CR21","unstructured":"Treadwell SJ. A paradox of support: the department of children and families and their construction of the \u201cgood mother\u201d. Master\u2019s Thesis. Digital Archives, Boston University. Boston: Boston University; 2016."},{"key":"3596_CR22","volume-title":"A collaborative approach to the treatment of women with opioid use disorders","author":"SAMHSA","year":"2016","unstructured":"SAMHSA. A collaborative approach to the treatment of women with opioid use disorders. 2016. Available from: https:\/\/store.samhsa.gov\/product\/A-Collaborative-Approach-to-the-Treatment-of-Pregnant-Women-with-Opioid-Use-Disorders\/SMA16-4978"},{"issue":"1","key":"3596_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ADM.0000000000000175","volume":"10","author":"M Terplan","year":"2016","unstructured":"Terplan M, Lawental M, Connah MB, Martin CE. Reproductive health needs among substance use disorder treatment clients. J Addict Med. 2016;10(1):20\u20135.","journal-title":"J Addict Med"},{"key":"3596_CR24","doi-asserted-by":"publisher","first-page":"118S","DOI":"10.1097\/01.AOG.0000558857.14568.07","volume":"133","author":"ASZ Moustafa","year":"2019","unstructured":"Moustafa ASZ, Kumar N, Masten M, Bruder A, Rocha F, Adekola H. Effects of methadone and buprenorphine use during pregnancy on neonatal and maternal outcomes [4K]. Obstet Gynecol. 2019;133:118S Available from: https:\/\/journals.lww.com\/greenjournal\/Abstract\/2019\/05001\/Effects_of_Methadone_and_Buprenorphine_Use_During.410.aspx. Cited 2019 Jun 27.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"3596_CR25","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/add.13462","volume":"111","author":"BK Zedler","year":"2016","unstructured":"Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115\u201328 Available from: http:\/\/onlinelibrary.wiley.com.ezproxy.bu.edu\/doi\/10.1111\/add.13462\/abstract. Cited 2018 Feb 21.","journal-title":"Addiction"},{"issue":"7","key":"3596_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/aje\/kwu190","volume":"180","author":"SB Brogly","year":"2014","unstructured":"Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol. 2014;180(7):673\u201386.","journal-title":"Am J Epidemiol"},{"key":"3596_CR27","unstructured":"U.S. Census Bureau. U.S. Census Regions. Available from: https:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf.\u00a0Accessed 15 Nov 2019."},{"key":"3596_CR28","volume-title":"Rural opioid prevention and treatment strategies: the experience in four states","author":"MS Gale","year":"2017","unstructured":"Gale MS, John A, Hansen MS, Elbaum Williamson MPAM. Rural opioid prevention and treatment strategies: the experience in four states. Portland: Maine Rural Health Research Center; 2017. (Research & Policy Briefs). Report no.: PB-63-2 April 2017"},{"issue":"Supplement C","key":"3596_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2017.01.011","volume":"76","author":"DJ Hand","year":"2017","unstructured":"Hand DJ, Short VL, Abatemarco DJ. Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region. J Subst Abuse Treat. 2017;76(Supplement C):58\u201363 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0740547216303361. Cited 2018 Jan 6.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"3596_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1370\/afm.2099","volume":"15","author":"CHA Andrilla","year":"2017","unstructured":"Andrilla CHA, Coulthard C, Larson EH. Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med. 2017;15(4):359\u201362 Available from: http:\/\/www.annfammed.org\/lookup\/doi\/10.1370\/afm.2099. Cited 2018 Mar 22.","journal-title":"Ann Fam Med"},{"key":"3596_CR31","volume-title":"Births financed by Medicaid","author":"Kaiser Family Foundation","year":"2016","unstructured":"Kaiser Family Foundation. Births financed by Medicaid. 2016. Available from: https:\/\/www.kff.org\/medicaid\/state-indicator\/births-financed-by-medicaid\/"},{"key":"3596_CR32","doi-asserted-by":"publisher","unstructured":"Patrick SW, Buntin MB, Martin PR, Scott TA, Dupont W, Richards M, Cooper WO. \u201cBarriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States.\u201d Substance Abuse 40, no. 3. 2019. https:\/\/doi.org\/10.1080\/08897077.2018.1488336. Accessed 15 Nov 2018.","DOI":"10.1080\/08897077.2018.1488336"},{"issue":"5","key":"3596_CR33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","volume":"123","author":"RJ Desai","year":"2014","unstructured":"Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3596_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.2153-9588.2012.01098.x","volume":"36","author":"H Hansen","year":"2012","unstructured":"Hansen H, Skinner ME. From white bullets to black markets and greened medicine: the neuroeconomics and neuroracial politics of opioid pharmaceuticals. Ann Anthropol Pract. 2012;36(1):167\u201382.","journal-title":"Ann Anthropol Pract"},{"issue":"2","key":"3596_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10826084.2017.1385633","volume":"53","author":"AE Hatcher","year":"2018","unstructured":"Hatcher AE, Mendoza S, Hansen H. At the expense of a life: race, class, and the meaning of buprenorphine in pharmaceuticalized \u201ccare\u201d. Subst Use Misuse. 2018;53(2):301\u201310 Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2017.1385633. Cited 2018 Apr 30.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"3596_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1377\/hlthaff.2011.0983","volume":"32","author":"B Saloner","year":"2013","unstructured":"Saloner B, Cook BL. Blacks and Hispanics are less likely than Whites to complete addiction treatment, largely due to socioeconomic factors. Health Aff (Millwood). 2013;32(1):135\u201345 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3570982\/. Cited 2019 May 29.","journal-title":"Health Aff (Millwood)"},{"key":"3596_CR37","unstructured":"Singer M, Ziegler J. The role of drug user stigmatization in the making of drug-related syndemics. In: Lerman, Ostrach, Singer, editors. Foundations of biosocial health: stigma and illness interactions: Lexington Books, Rowman & Littlefield; 2017."},{"key":"3596_CR38","volume-title":"Understanding CAPTA and state obligations","author":"National Advocates for Pregnant Women","year":"2018","unstructured":"National Advocates for Pregnant Women. Understanding CAPTA and state obligations. 2018. Available from: http:\/\/advocatesforpregnantwomen.org\/CAPTA%20requirements%20for%20states_NAPW.pdf"},{"key":"3596_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.childyouth.2019.01.042","volume":"99","author":"MH Lloyd","year":"2019","unstructured":"Lloyd MH, Luczak S, Lew S. Planning for safe care or widening the net?: A review and analysis of 51 states\u2019 CAPTA policies addressing substance-exposed infants. Child Youth Serv Rev. 2019;99:343\u201354 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0190740918309848. Cited 2019 May 31.","journal-title":"Child Youth Serv Rev"},{"key":"3596_CR40","volume-title":"Interprofessional-shared decision making for pregnant women with opioid use: results from a provider training","author":"H Howard","year":"2017","unstructured":"Howard H, Clark K. Interprofessional-shared decision making for pregnant women with opioid use: results from a provider training. 2017; Available from: https:\/\/www.ingentaconnect.com\/content\/ben\/cwhr\/2017\/00000013\/00000002\/art00010. Cited 2019 Nov 27."},{"issue":"3","key":"3596_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1360-0443.2009.02802.x","volume":"105","author":"U Zimmermann-Baer","year":"2010","unstructured":"Zimmermann-Baer U, N\u00f6tzli U, Rentsch K, Bucher HU. Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction. 2010;105(3):524\u20138.","journal-title":"Addiction"},{"key":"3596_CR42","volume-title":"Appalachian subregions","author":"Appalachian Regional Commission","year":"2002","unstructured":"Appalachian Regional Commission. Appalachian subregions. 2002. Available from: http:\/\/www.arc.gov\/images\/maps\/22512_Subregions.pdf"},{"key":"3596_CR43","volume-title":"Research methods in anthropology: qualitative and quantitative approaches","author":"HR Bernard","year":"2011","unstructured":"Bernard HR. Research methods in anthropology: qualitative and quantitative approaches. Lanham: Rowman Altamira; 2011."},{"key":"3596_CR44","volume-title":"Qualitative inquiry and research design: choosing among five approaches","author":"JW Creswell","year":"2012","unstructured":"Creswell JW. Qualitative inquiry and research design: choosing among five approaches. London: Sage Publications Ltd.; 2012."},{"key":"3596_CR45","volume-title":"Health policy in a time of crisis: abortion, austerity and access","author":"B Ostrach","year":"2017","unstructured":"Ostrach B. Health policy in a time of crisis: abortion, austerity and access. London: Routledge Press; 2017."},{"key":"3596_CR46","volume-title":"Constructing grounded theory: a practical guide through qualitative research","author":"K Charmaz","year":"2006","unstructured":"Charmaz K. Constructing grounded theory: a practical guide through qualitative research. London: SagePublications Ltd; 2006."},{"issue":"2","key":"3596_CR47","first-page":"21","volume":"2","author":"N Calvo","year":"2010","unstructured":"Calvo N, Cannon-DeKreek S, Dahms E, Kinkle SA, May B, Whalen S. Two perspectives on use of 4P\u2019s plus\u00a9 to screen pregnant women for alcohol and other drugs. Source. 2010;2(2):21.","journal-title":"Source"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03596-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03596-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03596-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T23:46:46Z","timestamp":1671320806000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03596-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3596"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03596-w","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The full study protocol was reviewed by the Institutional Review Board (research review staff) at the regional hospital that, at the time, reviewed all proposals for human subjects\u2019 research conducted by researchers based at the study setting<sup>6<\/sup>. Due to the de-identified and qualitative nature of data collection (interviews and participant-observation) the study was determined exempt (Category 2) by the IRB. All participants in the larger study gave verbal consent to participate; the ethics review committee approved and prefers a verbal consent process over written consent when a written consent form would be the only link between a participant and their data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}